Source: CORNELL UNIVERSITY submitted to NRP
E-SYNCH: A TOOL TO AUTOMATE AND OPTIMIZE CATTLE REPRODUCTIVE MANAGEMENT
Sponsoring Institution
National Institute of Food and Agriculture
Project Status
COMPLETE
Funding Source
Reporting Frequency
Annual
Accession No.
1014955
Grant No.
(N/A)
Cumulative Award Amt.
(N/A)
Proposal No.
(N/A)
Multistate No.
(N/A)
Project Start Date
Dec 8, 2017
Project End Date
Sep 30, 2021
Grant Year
(N/A)
Program Code
[(N/A)]- (N/A)
Recipient Organization
CORNELL UNIVERSITY
(N/A)
ITHACA,NY 14853
Performing Department
Animal Science
Non Technical Summary
We will develop the E-synch device, an easy to use, automated, and reusable tool for cattle reproductive management. E-synch (Electronic synchronization) will combine (1) an electronically-controlled intravaginal drug delivery device to enable the synchronization of ovulation with (2) sensing technology to monitor physiological parameters. E-synch will drastically reduce the need for labor-demanding, costly, and cow-disruptive injectable treatments. Physiological monitoring through sensors will allow individual cow-level, real time customization of protocols. Ultimately, E-synch will reduce the hassle of reproductive management promoting adoption and optimization of programs for artificial insemination (AI) which will help optimize the productivity and health of millions of cows around the world.The PDs teams' have an excellent track record of collaboration focusing on developing biomedical devices to improve cattle management. First, we will develop a prototype device and controlling software. Thereafter, we will test the prototype device under field conditions. This research will complement current efforts in Dr. Giordano's lab to optimize the response to intravaginal delivery of reproductive hormones in cattle and prior efforts by Dr. Erickson in engineering biomedical systems including controlled release drug delivery devices.Ultimately, E-synch will increase farm sustainability by reducing labor needs and improving cow welfare through better reproductive performance and reduced cow manipulation.
Animal Health Component
20%
Research Effort Categories
Basic
10%
Applied
20%
Developmental
70%
Classification

Knowledge Area (KA)Subject of Investigation (SOI)Field of Science (FOS)Percent
4027410202050%
3013499102030%
3013399310010%
3013499310010%
Goals / Objectives
Our overarching goal is to develop an electronically controlled and reusable device to fully automate delivery of reproductive hormones and monitor physiological parameters with automated sensors. Specific Objectives (SO) are:Specific Objective 1: Develop a prototype of the E-synch device. The device will be designed for intravaginal delivery of reproductive hormones in liquid or semi-solid form. E-synch will be inserted (not implanted) in the vagina and programed to release different amounts of reproductive hormone formulations at specific time intervals. The device will also include standard "off-the-shelf" motion, temperature, and pH sensors to monitor and adjust treatments to the physiological status of individual cows. We may refine our selection or develop custom sensors based on learnings during field testing. In parallel, we will develop a smart device app to control E-synch. The app will allow controlling and monitoring E-synch via Bluetooth on a standard iPad as well as visualizing and managing sensor data.Specific Objective 2: Test E-synch on farm. We will evaluate the feasibility of administering reproductive hormones with E-synch to elicit the desired physiological response. Specifically we will demonstrate the ability to controllably induce luteal regression with prostaglandin F2alpha (PGF) and luteinizing hormone (LH) release and ovulation after Gonadotropin Releasing Hormone (GnRH) treatment. Luteal regression and LH release (induces ovulation) are critical events for synchronization of ovulation.
Project Methods
Specific Objective 1: The first generation prototype E-synch device will consist of (1) up to 4 piston actuated drug delivery chambers to store hormones in fluid or semisolid form, (2) low-cost screw type motors to control amount and timing of delivery, (3) temperature, pH, and motion sensors, (4) microcontroller system with Bluetooth communication, and (5) battery.Each of the 4 hormone storage chambers will be filled individually with cartridges containing the hormone solution of interest. Thus, the device will be re-usable through replacement of the hormone-filled cartridges. The system will be controlled and monitored using a custom developed app implemented on an iPad. This app will allow users to fully customize treatments by selecting individual hormone release patterns (i.e., frequency, volume, and rate of delivery) or implement pre-loaded synchronization of ovulation protocols (e.g., Ovsynch, Double-Ovsynch).Algorithms will be included in the app to optimize timing of hormone release based on parameter data from the sensors (e.g., do not release while cows lay down to avoid flow of hormones out of the vagina and avoid release when temperature and/or pH may be inadequate for a maximal physiological response to hormones).Except for the app, the first generation prototype will include standard off-the-shelf components and a 3D printed housing to reduce development time.The dimensions of the device will be optimized to fit the vagina of cows of multiple sizes without causing discomfort and ensuring proper location during use. Biocompatible coatings, similar to those used previous by Prof. Erickson, will be used to ensure long-term stability and facilitate cleaning and disinfecting after use (device will be re-usable)..The temperature, pH, and motion sensors will: (1) optimize the response of cows to treatments. For example, to trigger or hold hormone release or adjust treatment frequency based on physiological status predicted based on sensor parameters, (2) monitor reproductive behavior for improved decision-making. For example, adjust timing of AI or use semen of different value based on estrus activity levels.Before Specific Objective 2, the functionality and accuracy of E-synch will be tested in a lab setting. Briefly, we will test the ability of E-synch to release specific quantities of the hormone products of interest at the frequency and duration used in synchronization of ovulation protocols. Prof. Erickson has significant experience in developing and implementing such validation protocols.Specific Objective 2: We will test the feasibility of using E-synch to induce luteal regression through PGF treatment and GnRH-induced LH and ovulation. Luteinizing hormone (LH) is released in response to GnRH and responsible for inducing ovulation. Trials will be conducted under equal conditions with lactating dairy cows from the Dairy Unit of the Cornell Ruminant Center in Hartford, NY. For each experiment, cows will receive the Ovsynch protocol (GnRH, 7 d later PGF, 24 h later PGF, 32 h later GnRH) through intramuscular (i.m.) injections to synchronize ovulation before testing E-synch. This protocol allows to synchronize ovulation so that cows can receive treatments at specific stages of the estrous cycle when the reproductive hormones of interest are used in synchronization of ovulation protocols.In these experiments we will also demonstrate the ability of the device to monitor physiological parameters (i.e., pH, temperature, physical activity). Data for the physiological parameters of interest will be compared to gold standard methods. Vaginal temperature and pH will be collected with intravaginal loggers and motion data will be collected with leg-attached accelerometers.In Experiment 1, we will test the efficacy of intravaginal administration of PGF through E-synch to induce luteal regression 8 days after the second GnRH of Ovsynch. Cows will be blocked by parity, stratified by days in milk and milk yield and then randomly assigned to (n = 90; 30 per group): 1) IM-Control: 25 mg of PGF (Dinoprost) i.m. (regular dose of PGF to induce luteolysis in cattle), 2) E-synch-PGF: two 25 mg doses of PGF delivered by E-synch 12 h apart (most effective based on our previous data from Wijma et al., 2016), and 3) E-synch-CON: two 5 mL doses of saline delivered by E-synch 12 h apart (same volume of solution given to E-synch-PGF group). Blood samples will be collected at -1 h, every 6 h from 0 h to 24 h, and every 12 h up to 96 h after treatment to determine circulating concentrations of progesterone. Differences in progesterone concentrations dynamics between treatment groups will be analyzed for the whole sampling period. Luteal regression (<1 ng/mL of progesterone) in response to PGF treatment will be determined at 48, 56, and 72 h after treatment. Ovarian ultrasonography will also be conducted at the time of blood sample collection to aid in determination of luteal regression.In Experiment 2, we will test the efficacy of intravaginal administration of GnRH with E-synch to induce LH release and ovulation. Nine days after completion of the setup Ovsynch, cows (n = 90; 30 per group) will receive an i.m. PGF treatment to induce luteal regression. Forty eight hours after the PGF, cows will be randomly assigned to receive: 1) IM-Control: 100 µg of GnRH i.m. (regular dose of GnRH), 2) E-synch-GnRH: 1,000 µg of GnRH with 10% citric acid delivered with E-synch (most effective dose based on our previous research; Wijma et al., 2017), and 3) E-synch-CON: 10 mL of GnRH with E-synch (same volume of solution given to E-synch-GnRH group). Blood samples will be collected for determination of progesterone and estradiol concentrations at the time of treatment to confirm response to the synchronization of ovulation protocol, and the hormonal milieu before treatment (both progesterone and estradiol levels can affect the response to GnRH). To determine circulating concentrations of LH, blood samples will be obtained from the jugular vein using a syringe attached to an indwelling jugular catheter. Samples will be collected every 15 min from -15 min to 4 h after treatment and every 30 min from 4 to 8 h after treatment. Ovulation after treatment will be determined through ovarian ultrasonography conducted every 8 h from 12 to 48 h after treatment.We expect that the response of interest (i.e., reduction in circulating progesterone and luteal regression for PGF and LH release for GnRH) will be similar for cows that receive the hormonal treatments through the IVG route with E-synch compared with cows that receive PGF and GnRH through intramuscular injection. We also expect cows in the E-synch-CON group to not present the physiological response observed in cows that receive PGF and GnRH treatments with E-synch or through intramuscular injections. Once we determine that the profiles for progesterone and LH are physiologically equivalent (not necessarily the same) we will conduct additional experiments to identify IVG treatment regimens (i.e., dose, volume, frequency of administration) that optimize luteal regression in response to PGF and ovulation in response to GnRH given through the IVG route. These experiments, not performed under this grant, will include larger number of cows because luteal regression and ovulation are binomial outcomes for which hundreds of observations are needed to compare an alternative treatment strategy to the gold standard (i.e., i.m. injection).

Progress 12/08/17 to 09/30/21

Outputs
Target Audience:The target audience for this research has been broad. A main target audience has been the scientific community through our presentations at conferences and in peer reviewed publications. We have also targeted dairy industry stakeholders including producers, consultants, extension personnel, and pharmaceutical companies. These stakeholders have been reached directly through presentations, farm visits, and indirectly through publications in scientific Journals, conferences, training for veterinarians, and our interactions with many other multipliers of information (i.e., breeding companies, pharmaceutical companies). Graduate and undergraduate students in Animal Science, Veterinary Medicine, and Engineering programs have also been reached. Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?Graduate student training - through this research project six graduate students from Animal Science and Mechanical Engineering (4 PhD and 2 MS) have been trained in multiple aspects of biomedical device engineering and research with dairy cattle. Students were involved with design and testing of e-Synch prototype devices and research experiments evaluating the feasibility of intravaginal hormone delivery. Activities performed with cows included synchronization of ovulation, transrectal and transvaginal ultrasonography, blood sample collection, laboratory assays (RIA and ELISA), and use of statistical and dairy management software. Graduate students participated of and presented at scientific and industry oriented conferences, drafted manuscripts for publication in peer-reviewed journals, and were trained on manuscript submission and handling for publication. Undergraduate students (n = 4), interns (n = 4), and postdoc (n = 1) training - these individuals have been involved with on-farm data collection, data processing, sample processing, and basic aspects of laboratory techniques. For example, students and interns were trained on blood sampling, transrectal ultrasonography, and use of dairy management software. These students and interns provided support to graduate students, technicians, and the PIs. They also participated of experiment planning and evaluation in weekly laboratory meetings. The PIs have directly worked with students and interns on their training. Research collaborations - this project is a collaboration between the research laboratories of Dr. Giordano in the Department of Animal Science in the College of Agriculture and Life Science and Professor David Erickson at the School of Engineering at Cornell University. Students from both research groups and the project directors work in collaboration on the design of the e-Synch device and evaluation of performance of the e-Synch device in the field. Both research groups have regular in person meetings to discuss progress and delineate future activities. How have the results been disseminated to communities of interest?Results from this research project have been published in peer reviewed journal publications, abstracts and presentations at the annual meeting of the Dairy Science Association, the Cornell Initiative for Digital Agriculture annual workshop, and the annual meeting of the Dairy Cattle Reproduction Council. Other audiences have been reached through presentations, farm visits, and indirectly through our publications in scientific journals, scientific meetings, training for veterinarians, and working with the many other multipliers of information (i.e., AI companies, pharmaceutical companies, nutritionists, extension personnel, others). What do you plan to do during the next reporting period to accomplish the goals? Nothing Reported

Impacts
What was accomplished under these goals? Impact Statement We developed and tested a novel technology to improve fertility management of cattle. The e-Synch is an easy to use, electronically controlled fully automated hormone delivery and sensing device for enabling synchronization of estrus and ovulation for artificial insemination of cattle. Automated hormone delivery and sensing can drastically reduce the need for labor-demanding, costly, and cow-disruptive injectable treatments. Thus, the e-Synch has the potential to improve the profitability and sustainability of cattle operations through improved animal management and well-being, improved reproductive performance, and reduced farm labor needs and cost. Under Objective 1 Our aim was to develop a prototype of the E-synch device. Our team designed and tested in vitro and in vivo multiple prototypes and a first version of a controlling smartphone and computer application. In each iteration, we evaluated different shapes and sizes of the device carcass and holding mechanism, diverse mechanisms to control hormone delivery, different number, type, and shape of hormone reservoirs, different types of control board, different battery types and sizes, and types and location of sensors. The latest version of the protype device comprises an outer 3D-printed plastic housing, two silicone hormone reservoirs (~5 mL) connected to individual delivery pumps, a printed circuit board (PCB) powered by a rechargeable battery, and a retention mechanism. To ensure ease of insertion and minimize irritation of the vaginal mucosa, the device is coated with skin-safe silicone rubber. Using this last version of e-Synch, two devices were tested in vitro to evaluate precision and accuracy for delivering different target volumes of saline solution. For volumes in the 0.1 to 1.0 mL range, all observations fell within the limits of agreement, whereas one observation from one pump (-0.06 mL, or 3% of target dose) and one observation from another pump (0.03 mL, or 1.5% of target dose) fell outside the limits of agreement for the 2.0 mL dose. The overall difference between target and actual dose averaged -0.005 mL, which is less than a drop of water (0.05 mL) and indicated overall good agreement between target and released amount. We also evaluated fluid release in the long-term. e-Synch devices (n = 2) were programmed to release 1 dose (2 mL) of distilled water at 0, 12, 24, and 36 h. We observed accurate (< 5% average error) release of 2.0 mL of distilled water from each reservoir as programmed. In parallel, work was conducted to develop communication capacity with external controlling sources and sensing. We improved functionality of sensors for monitoring behavioral and physiological parameters (i.e., activity and temperature). Controlling software and application were developed and subsequently modified to accommodate programing to control delivery, sensing, and the user interface. Collectively, these work and results provided evidence that a functional prototype e-Synch device could be developed and programmed to accurately release reproductive hormones in a liquid from in a timely and precise manner. Releasing specific reproductive hormones in a timely manner and in the correct dose is critical for eliciting desired physiological responses in vivo. Under Objective 2 The aim was to test e-Synch prototypes on farm. Specifically, we aimed to evaluate the feasibility of inducing complete luteal regression with prostaglandin F2alpha (PGF) and luteinizing hormone (LH) release after Gonadotropin Releasing Hormone (GnRH) treatment. Luteal regression and LH release (induces ovulation) are critical events for synchronization of ovulation. In a series of proof-of-concept experiments, we evaluated the ability of prototype devices to release hormones or saline solution, the holding mechanism, and the ability of the device to communicate with the controlling device while in the cow. These preliminary experiments provided valuable insights for re-design and re-configuration of the device before experiments aimed at demonstrating the ability to cause physiological responses after administration of reproductive hormones with e-Synch. In experiment 1, we tested the hypothesis that it would be possible to induce corpus luteum regression after PGF delivery with e-Synch. Briefly, cows with ≥1 functional corpus luteum (CL) were randomly allocated to a positive control group (IM-PGF; n=6), a group that received an e-Synch device loaded with PGF (DEV-PGF; n = 6), and a placebo control group which received an empty e-Synch device (DEV-CTRL; n = 4). Cows in DEV-PGF received four doses of 25 mg of PGF 12 h apart. All devices remained in situ until removed at 48-h. Concentrations of Progesterone (P4) did not differ at time 0 but differed from 24 to 72 h as cows in IM-PGF and DEV-PGF had lesser P4 than cows in DEV-CTL. Conversely, P4 after treatment did not differ for the IM-PGF and DEV-PGF groups. None of the e-Synch-treated cows showed signs of distress or abnormalities in behavior, and no erosions of the vaginal mucosa were observed. Thus, we concluded that the e-Synch prototype can be programmed to automatically release PGF for induction of luteal regression in lactating dairy cows. In experiment 2, we tested the hypothesis that delivery of GnRH with e-Synch would cause LH release as evidenced by a surge of LH within 8 h of delivery. Lactating Holstein cows were randomly assigned to a positive control group that received 100 μg of GnRH by intramuscular injection (IM-GnRH; n = 6), a 100 μg of GnRH in 10% citric acid by intravaginal delivery with e-Synch (DEV-GnRH; n = 6), and a placebo control group which received an empty e-Synch device (DEV-CON; n = 5). Vaginal integrity and overall cow response to e-Synch were also evaluated. No detrimental effects of e-Synch on vaginal integrity and overall cow behavior were observed. Circulating concentrations of LH after treatment indicated a normal response after i.m. injection of GnRH whereas neither cows that received or did not receive GnRH with e-Synch had a detectable increase in circulating concentrations of LH. Thus, we concluded that administration of 100 μg of GnRH in 10% citric acid with e-Synch failed to elicit the desired LH response. Results form this experiment indicated that different doses or volumes of administration would be necessary to cause a surge of LH of normal magnitude. In experiment 3, we tested the effect on LH release of different doses and volumes of administration of GnRH with e-Synch. Lactating Holstein cows were randomly assigned (n = 6/group) to a positive control group that received a 100 μg of GnRH i.m. or GnRH in a 10% citric acid solution in the following amounts and volumes: 100 μg in 2 mL, 100 μg in 10 mL, 1,000 μg in 2 mL, and 1,000 μg in 10 mL. Circulating concentrations of LH followed a typical LH surge pattern and were similar from 1 to 6 h after treatment for cows in the IM-GnRH and cows that received 1,000 μg of GnRH in 2 or 10 mL of solution. Conversely, the 100 μg dose of GnRH in 2 or 10 mL did not elicit a surge of LH from 1 to 6 h after treatment. Thus, we concluded that it is possible to induce a surge of LH of the same magnitude than after intramuscular injection or intravaginal delivery of GnRH with the e-Synch device. Nevertheless, the dose of GnRH required for successful induction of an LH surge after intravaginal delivery with e-Synch was greater than that required after intramuscular injection. Taken together, key findings from the experiments conducted under Objective 2 were that it is plausible to induce complete luteal regression and an LH surge of normal magnitude after intravaginal delivery of PGF and GnRH with the current prototype of the e-Synch device. Nevertheless, larger doses of PGF and GnRH were required to elicit the desired physiological responses.

Publications

  • Type: Journal Articles Status: Published Year Published: 2019 Citation: Masello M., M. Scarbolo, M.V. Schneck, M.M. Perez, E.M. Schillkowsky, E.M. Sitko, F. Sosa Hernandez, E.M. Cabrera, R.M. Rossi, and J.O. Giordano. 2019. Efficacy of Intravaginal Administration of PGF2 alpha for induction of Luteal Regression in Lactating Dairy Cows. J. Dairy Sci. Volume 102, E-Supplement 1. (Abstract)
  • Type: Journal Articles Status: Published Year Published: 2020 Citation: Masello M., M. Scarbolo, M.V. Schneck, M.M. Perez, E.M. Schillkowsky, E.M. Sitko, F. Sosa Hernandez, E.M. Cabrera, R.M. Rossi, and J.O. Giordano*. 2020. Intravaginal instillation of prostaglandin F2 alpha was as effective as intramuscular injection for induction of luteal regression in lactating dairy cows. J. Dairy Sci. 103:27432755. DOI: https://doi.org/10.3168/jds.2019-17589
  • Type: Conference Papers and Presentations Status: Published Year Published: 2019 Citation: Masello M, Scarbolo M, Schneck MV, Perez MM, Schillkowsky EM, Sitko EM, Hernandez FS, Cabrera EM, Rossi RM, Giordano JO. Intravaginal instillation of prostaglandin-F2alpha was as effective as intramuscular injection for induction of luteal regression in lactating dairy cows. Presentation at the Annual Meeting of the American Dairy Science Association. June 26th, 2019. Cincinnati, Ohio, USA.
  • Type: Conference Papers and Presentations Status: Published Year Published: 2019 Citation: Magdalena Masello, Yue Ren, David Erickson, and Julio Giordano. e-Synch: Automating Reproductive Management of Cattle. Cornell Initiative for Digital Agriculture Workshop. October, 24th 2019. Ithaca, New York, USA.
  • Type: Conference Papers and Presentations Status: Published Year Published: 2019 Citation: Masello M., Scarbolo M., Schneck M.V., Perez MM, Schillkowsky E.M., Sitko E.M., Hernandez F.S., Cabrera E.M., Rossi R.M., Giordano J.O. Intravaginal instillation of prostaglandin-F2alpha was as effective as intramuscular injection for induction of luteal regression in lactating dairy cows. Poster presentation at the Annual Meeting of the Dairy Cattle Reproduction Council. November 13th, 2019. Pittsburgh, Pennsylvania, USA.
  • Type: Journal Articles Status: Published Year Published: 2020 Citation: M. Masello, Y. Ren, D. Erickson, and J. O. Giordano. An automated controlled-release device for intravaginal hormone delivery. 2020. J. Dairy Sci. Comm. 1:15-20. DOI: https://doi.org/10.3168/jdsc.2020-18816
  • Type: Theses/Dissertations Status: Published Year Published: 2020 Citation: Improving Reproductive Performance of Cattle through the Development of Novel Management Strategies and Technologies. Masello Souza, Magdalena. Cornell University, ProQuest Dissertations Publishing, 2020. 27993848.
  • Type: Journal Articles Status: Published Year Published: 2020 Citation: Masello M., Y. Ren, D. Erickson, and J. O. Giordano. 2020. An electronically-controlled intravaginal hormone delivery device successfully induced luteal regression in dairy cattle. J. Dairy Sci. Volume 103. E-Supplement 1. (Abstract)


Progress 10/01/19 to 09/30/20

Outputs
Target Audience:The target audience for the outcomes of our research is broad. Initially it will be primarily the scientific community. Upon completion of experiments with a functional device under farm conditions, our target audience will expand to dairy industry stakeholders including producers, consultants, and extension personnel. We plan on reaching out to stakeholders directly through presentations, farm visits, and indirectly through our publications in scientific Journals, scientific meetings, training for veterinarians, and working with the many other multipliers of information (i.e., AI companies, pharmaceutical companies, nutritionists, extension personnel, others). Changes/Problems:We requested a no cost extension for this project because the COVID pandemic prevented our team from completing the project on time. Our team is working diligently on completing the research. What opportunities for training and professional development has the project provided?Graduate student training - through these research project four graduate students from Animal Science and Mechanical Engineering (3 PhD and 1 MS) have been trained in multiple aspects of biomedical device engineering and research with dairy cattle. Students have been involved with design and testing of the prototype devices and research experiments evaluating the feasibility of intravaginal hormone delivery. Activities performed with cows included synchronization of ovulation in cattle, transrectal and transvaginal ultrasonography, blood sample collection, laboratory assays (RIA and ELISA), and use of statistical and dairy management software. Undergraduate students (n = 2), interns (n = 2), and postdoc (n = 1) training - these individuals have been involved with on-farm data collection, data processing, sample processing, and basic aspects of laboratory techniques. For example, students and interns were trained on blood sampling, transrectal ultrasonography, and use of dairy management software. These students and interns provided support to graduate students, technicians, and the PI. They also participated of experiment planning and evaluation in weekly laboratory meetings. The PI has directly worked with students and interns on their training. Research collaborations - this project is a collaboration between the research laboratories of Dr. Giordano in the Department of Animal Science in the College of Agriculture and Life Science and Professor David Erickson at the School of Engineering at Cornell University. Students from both research groups and the project directors work in collaboration on the design of the e-Synch device and evaluation of performance of the e-Synch device in the field. Both research groups have regular in person meetings to discuss progress and delineate future activities. How have the results been disseminated to communities of interest?Results from the experiments conducted and the overall research project have been published in peer reviewed journal publications, abstracts and presentations at the annual meeting of the Dairy Science Association, the Cornell Initiative for Digital Agriculture annual workshop, and the annual meeting of the Dairy Cattle Reproduction Council. What do you plan to do during the next reporting period to accomplish the goals?During the next reporting period, we will complete the laboratory assay work needed to determine the response to intravaginal delivery of GnRH with e-Synch. Additional on-farm experiments will be conducted to evaluate the biological response of cows to intravaginal delivery of GnRH if we observe that the treatment regimens evaluated in our last experiment were ineffective. Once the feasibility of inducing sufficient LH release after automated delivery of GnRH is demonstrated, we will conduct experiments to determine ovulatory response to intravaginal delivery of GnRH (ultimate outcome of interest). Assuming that we will be successful at inducing ovulation, we will conduct additional experiments to evaluate the feasibility of synchronizing ovulation after fully automated release of GnRH and PGF2alpha as part of an Ovsynch protocol (i.e., timed artificial insemination protocol). We will also work on re-designing device features based on observations from the on-farm experiments. We will continue improving e-Synch to maximize retention rates while ensuring ease of insertion and removal. In addition, we will work on integrating sensors for monitoring behavioral and physiological parameters along with e-Synch communication with external controlling devices.

Impacts
What was accomplished under these goals? During this reporting period we made progress towards accomplishment of the specific objectives of the project, published a manuscript in a peer-reviewed journal, filed a provisional patent application, and continued working on training a number of students and other professionals. We secured funding to further the development and evaluation of e-Synch beyond the completion of this project. Our team was awarded a grant from the National Institute of Agriculture under the AFRI Foundational and Applied Science program for FY 2020. Under Specific Objective 1 we continued improving the e-Synch device. Communication with external controlling sources was evaluated under field conditions. We improved functionality of sensors for monitoring behavioral and physiological parameters. Controlling software and application were further developed to improve functionality. Under Specific Objective 2 we conducted an experiment to evaluate functionality of the latest e-Synch device, the effect of e-Synch on cow vaginal integrity, and luteinizing hormone (LH) release after intravaginal delivery of GnRH by e-Synch. In this experiment, lactating dairy cows from the Cornell University Ruminant Center received GnRH through intramuscular injection or intravaginal delivery by the e-Synch device. Blood samples were collected to determine circulating concentrations of LH for up to 8 h after treatment. Vaginal integrity and overall cow response to e-Synch were evaluated. Laboratory work focused on determination of circulating concentrations of LH by radioimmunoassay and ELISA. Preliminary evaluation of vaginal integrity and overall cow response to e-Synch suggest no major detrimental effects of e-Synch on cows. Once laboratory work is completed, results from this experiment will indicate if our approach was successful at inducing a surge of LH of similar magnitude than observed after intramuscular injection of GnRH. Additional experiments with different GnRH release regimens (i.e., different doses, absorption enhancers, frequency of release) will be tested if the LH response after intravaginal delivery with e-Synch is inferior as compared with intramuscular injection.

Publications

  • Type: Journal Articles Status: Published Year Published: 2020 Citation: An automated controlled-release device for intravaginal hormone delivery. 2020. M. Masello, Y. Ren, D. Erickson, and J. O. Giordano. J. Dairy Sci. Comm. 1:15-20. DOI: https://doi.org/10.3168/jdsc.2020-18816
  • Type: Theses/Dissertations Status: Published Year Published: 2020 Citation: Improving Reproductive Performance of Cattle through the Development of Novel Management Strategies and Technologies. Masello Souza, Magdalena. Cornell University, ProQuest Dissertations Publishing, 2020. 27993848.


Progress 10/01/18 to 09/30/19

Outputs
Target Audience:The target audience for the outcomes of our research is broad but initially it will be primarily the scientific community. Upon completion of experiments with a functional device under farm conditions, our target audience will expand to dairy industry stakeholders including producers, consultants, and extension personnel. We plan on reaching out to stakeholders directly through presentations, farm visits, and indirectly through our publications in scientific Journals, scientific meetings, training for veterinarians, and working with the many other multipliers of information (i.e., AI companies, pharmaceutical companies, nutritionists, extension personnel, others). Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?Graduate student training - through these research project 4 graduate students from Animal Science and Mechanical Engineering (3 PhD and 1 MS) have been trained in multiple aspects of biomedical device engineering and research with dairy cattle. Students have been involved with design and testing of the prototype devices and research experiments evaluating the devices with cows and the feasibility of intravaginal hormone delivery. Activities performed with cows included synchronization of ovulation and estrus in cattle, transrectal and transvaginal ultrasonography, blood sample collection, laboratory assays (RIA and ELISA), and use of statistical and dairy management software. Undergraduate students (n = 4) and interns (n = 5) training - these individuals have been involved with on-farm data collection, data processing, sample processing, and basic aspects of laboratory techniques. For example, students and interns were trained on blood sampling, transrectal ultrasonography, and use of dairy management software. These students and interns provided support to graduate students, technicians, and the PI. When possible they also participated of experiment planning and evaluation in weekly laboratory meetings. The PI has directly worked with students and interns on their training. Research collaborations - this project in a collaboration between Dr. Giordano in the Department of Animal Science in the College of Agriculture and Life Science and Professor David Erickson at the School of Engineering at Cornell University. Students from both research groups and the project directors work in collaboration on the design of the e-Synch device and performance of the device in the field. Both research groups have regular in person meetings to discuss progress and delineate future activities. How have the results been disseminated to communities of interest?Preliminary results from the experiments conducted to evaluate e-Synch as a means to deliver PGF for induction luteal regression have been presented at the 2019 Annual Meeting of the Dairy Science Association, at the 3rd Annual Cornell Initiative for Digital Agriculture Workshop (2019), and at the 2019 Annual Meeting of the Dairy Cattle Reproduction Council. Results from our last experiment will be presented at 2020 Annual Meeting of the American Dairy Science Association. What do you plan to do during the next reporting period to accomplish the goals?During the next reporting period, additional on-farm experiments will be conducted to evaluate the biological response of cows to intravaginal delivery of other reproductive hormones of interest. For instance, we will evaluate luteinizing hormone release and ovulation after intravaginal GnRH delivery with e-Synch. Once the feasibility of automated GnRH delivery for induction of ovulation is demonstrated, we will conduct larger experiments where we evaluate completion of synchronization after fully automated Ovsynch and Ovsynch-type protocols (i.e., timed artificial insemination protocols using PGF and GnRH hormones). As done previously, we will re-design device features as needed based on observations from the on-farm experiments. We will also continue to improve the design of e-Synch to maximize retention rates while ensuring ease of insertion and removal. In addition, we will work on the integration of seniors to monitor behavioral and physiological parameters and the communication of e-Synch with external controlling devices, including the optimization and validation of the controlling app.

Impacts
What was accomplished under these goals? During this reporting period, our group made significant progress to accomplish the objectives of this project. Under Specific Objective 1 we developed and tested different models of the e-Synch device. For each iteration, we worked on improving the shape and size of the 3D-printed device carcass, the retention mechanism, and the type and shape of the hormone reservoirs. We also worked on improving the device coating material and applicator size to ensure ease of insertion and avoid damage to the vaginal mucosa. In terms of device performance in vitro, we evaluated precision and accuracy of delivering different target volumes of saline solution. Preliminary in vitro observations suggest that e-Synch can be programmed to accurately deliver different target doses (range 0.1 to 2.0 mL) with less than 1% error. In addition, long-term (i.e., 2 days) in vitro testing showed that e-Synch is able to release target doses at specific time intervals (i.e., one dose every 12 h) with high precision. This is relevant because eliciting the desired physiological response in vivo (i.e., luteal regression after PGF and ovulation after GnRH treatment) not only requires accurate delivery of the target volume, but also precise timing of hormone release. Under Specific Objective 2 we evaluated the performance of each of the developed prototypes under field conditions (i.e., on farm with live cows). Briefly, multiple experiments were conducted to evaluate the ability of the prototype devices to release hormones or saline solution and to assess device retention. These experiments provided valuable feedback for re-design and configuration of the device design. For instance, coating material, shape and format of the hormone reservoirs, retention type, and applicator size were all re-designed based on observations from these on-farm experiments. After multiple rounds of re-design of the device features, our latest prototype version includes a programmable board for automated and wireless delivery, an upgraded retention mechanism, skin safe coating material to alleviate any possible reactions of the vaginal mucosa, smaller device and applicator size, and optimized hormone reservoir for improved delivery. In a recent proof of concept experiment, we evaluated the feasibility of inducing corpus luteum regression in live cows using the latest version of the e-Synch device. Briefly, e-Synch devices were loaded with PGF and programmed to release one dose every 12 h (up to 4). Devices were then inserted into the vagina of lactating dairy cows (n = 6) and removed 48 h later. Results from this experiment showed no differences in progesterone profiles between cows treated with e-Synch devices and cows receiving the standard intramuscular treatment, with all cows undergoing complete luteal regression (i.e., circulating progesterone < 1 ng/mL). None of the e-Synch-treated cows showed signs of distress or abnormalities in behavior at any time during the study period, and no erosions of the vaginal mucosa were observed after device removal. Collectively, these results support the feasibility of automated intravaginal delivery of PGF with e-Synch to induce luteal regression in lactating dairy cattle. Results from this experiment will be presented at the 2020 Annual Meeting of the American Dairy Science Association.

Publications

  • Type: Journal Articles Status: Published Year Published: 2019 Citation: Masello M, Scarbolo M, Schneck MV, Perez MM, Schillkowsky EM, Sitko EM, Hernandez FS, Cabrera EM, Rossi RM, Giordano JO. Intravaginal instillation of prostaglandin-F2alpha was as effective as intramuscular injection for induction of luteal regression in lactating dairy cows. J Dairy Sci. 2019 Dec 24. pii: S0022-0302(19)31133-6. doi: 10.3168/jds.2019-17589.
  • Type: Conference Papers and Presentations Status: Published Year Published: 2019 Citation: Masello M, Scarbolo M, Schneck MV, Perez MM, Schillkowsky EM, Sitko EM, Hernandez FS, Cabrera EM, Rossi RM, Giordano JO. Intravaginal instillation of prostaglandin-F2alpha was as effective as intramuscular injection for induction of luteal regression in lactating dairy cows. Presentation at the Annual Meeting of the American Dairy Science Association. June 26th, 2019. Cincinnati, Ohio, USA.
  • Type: Conference Papers and Presentations Status: Published Year Published: 2019 Citation: Magdalena Masello, Yue Ren, David Erickson, and Julio Giordano. e-Synch: Automating Reproductive Management of Cattle. Cornell Initiative for Digital Agriculture Workshop. October, 24th 2019. Ithaca, New York, USA.
  • Type: Conference Papers and Presentations Status: Published Year Published: 2019 Citation: Masello M, Scarbolo M, Schneck MV, Perez MM, Schillkowsky EM, Sitko EM, Hernandez FS, Cabrera EM, Rossi RM, Giordano JO. Intravaginal instillation of prostaglandin-F2alpha was as effective as intramuscular injection for induction of luteal regression in lactating dairy cows. Poster presentation at the Annual Meeting of the Dairy Cattle Reproduction Council. November 13th, 2019. Pittsburgh, Pennsylvania, USA.


Progress 12/08/17 to 09/30/18

Outputs
Target Audience:The target audience for the outcomes of our research is broad but initially it will be primarily the scientific community. Upon completion of experiments with a functional device under farm conditions, our target audience will expand to dairy industry stakeholders including producers, consultants, and extension personnel. We plan on reaching out to stakeholders directly through presentations, farm visits, and indirectly through our publications in scientific Journals, scientific meetings, training for veterinarians, and working with the many other multipliers of information (i.e., AI companies, pharmaceutical companies, nutritionists, extension personnel, others). Changes/Problems: Nothing Reported What opportunities for training and professional development has the project provided?Graduate student training - through these research project 4 graduate students from Animal Science and Mechanical Engineering (3 PhD and 1 MS) have been trained in multiple aspects of biomedical device engineering and research with dairy cattle. Students have been involved with design and testing of the prototype devices and research experiments evaluating the devices with cows and the feasibility of intravaginal hormone delivery. Activities performed with cows included studies synchronization of ovulation and estrus in cattle, transrectal and transvaginal ultrasonography, blood sample collection, laboratory assays (RIA and ELISA), and use of statistical and dairy management software. Undergraduate students (n = 4) and interns (n = 5) training - these individuals have been involved with on-farm data collection, data processing, sample processing, and basic aspects of laboratory techniques. For example, students and interns were trained on blood sampling, transrectal ultrasonography, and use of dairy management software. These students and interns provided support to graduate students, technicians, and the PI. When possible they also participated of experiment planning and evaluation in weekly laboratory meetings. The PI has directly worked with students and interns on their training. Research collaborations - this project in a collaboration between Dr. Giordano in the Department of Animal Science in the College of Agriculture and Life Science and Professor David Erickson at the School of Engineering at Cornell University. Students from both research groups and the project directors work in collaboration on the design of the e-Synch device and performance of the device in the field. Both research groups have regular in person meetings to discuss progress and delineate future activities. How have the results been disseminated to communities of interest?Results from the experiments conducted to evaluate luteal regression in response to intravaginal delivery of PGF will be presented at the 2019 Annual Meeting of the Dairy Science Association. What do you plan to do during the next reporting period to accomplish the goals?During the next reporting period we will continue improving the design of the e-Synch to optimize hormone delivery, retention, communication with external controlling devices, and an ergonomic design to maximize cow comfort during insertion. We will continue to test prototype devices under field conditions before larger experiments can be conducted to evaluate completion of synchronization of ovulation protocols with the final version of the device. Additional experiments will be conducted to evaluate the biological response of cows to intravaginal delivery of reproductive hormones of interest.

Impacts
What was accomplished under these goals? During this reporting period our group made significant progress to accomplish the objectives of this project. Under Specific Objective 1 we developed and tested four different models of the e-Synch device. We also developed the controlling smartphone application. For each iteration, we worked on different shapes and sizes of the device carcass and holding mechanism, diverse mechanisms to control hormone delivery, different number, type, and shape of hormone reservoirs, different types of control board, different type and size of batteries, and types and location of sensors in the device. The controlling app was developed and was subsequently modified to accommodate programing to control delivery, sensing, and the user interface. Under Specific Objective 2 we tested each of the prototypes created under field conditions (i.e., on farm with live cows). In multiple experiments we evaluated the ability of the prototype devices to release hormones or saline solution, the holding mechanism, and the ability of the device to communicate with an antenna and controlling device while inserted in the vagina of a cow. In an proof of concept experiment with our first prototype device (wired device), we demonstrated the feasibility of inducing luteal regression after delivery of two doses of PGF 12 h apart. These data were used as preliminary observations for a grant proposal submitted to the AFRI Foundational program from USDA-NIFA for fiscal year 2018. Additional experiments conducted with subsequent versions of the e-Synch device provided valuable feedback for re-design and configuration of the device. To provide additional supportive evidence of the feasibility of inducing the expected biological response after intravaginal treatment with reproductive hormones, we conducted an experiment to compare physiological and behavioral responses after intravaginal or intramuscular delivery of prostaglandin F2 alpha (PGF). Using lactating dairy cows as our model, we evaluated the proportion of cows with luteal regression based on circulating progesterone concentrations, the proportion of cows detected in estrus, and ovulatory response after estrus. Preliminary observations suggest no difference in luteal regression and progesterone profiles in response to intravaginal or intramuscular delivery of PGF. In addition, we did not observe differences between experimental groups for estrus expression, ovulation risk, and pregnancies per AI after insemination. Collectively, these results support the feasibility of intravaginal delivery of PGF to induce luteal regression in lactating dairy cattle. Results from this experiments will be presented at the 2019 Annual Meeting of Dairy Science Association.

Publications

  • Type: Conference Papers and Presentations Status: Accepted Year Published: 2019 Citation: M. Masello*, M. Scarbolo, M.V. Schneck, M.M. Perez, E.M. Schillkowsky, E.M. Sitko, F. Sosa, Hernandez, E.M. Cabrera, R.M. Rossi, J.O. Giordano. Efficacy of Intravaginal Administration of PGF2alpha for induction of Luteal Regression in Lactating Dairy Cows. (Abstract) Journal of Dairy Science e-Supplement.